Plenary V: HLA-Peptide Targeting and Personalized Medicine

T Cell Redirection in Uveal Melanoma: A New Therapeutic Modality for the Treatment of Solid Tumors

Friday, October 10, 2025

9:30 AM - 10:00 AM US EDT

Speaker(s)

Richard Carvajal, MD

Professor of Medicine
Northwell Health Cancer Institute
Lake Success, NY